Breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients: (1)Pathologically diagnosed with breast cancer and having received =18 years; (4)Signed informed consent, voluntarily participating in the intervention trial. 2. Nurses: (1)Engaged in clinical nursing practice; (2)Possess a valid Nurse Practicing Certificate; (3)Voluntarily participate in the study and provide signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Exclusion Criteria for Patients: (1)In the terminal stage of disease or in critical condition; (2)History of psychiatric disorders, or dysfunction in sensory perception such as pain, temperature, or touch sensation; (3)Injection site already showing signs of adverse reactions such as bruising, ecchymosis, subcutaneous induration, redness, or swelling; (4)Bleeding tendency, with abnormal platelet count or coagulation function. 2. Exclusion Criteria for Nurses: (1)Nurses absent from duty due to sick leave, maternity leave, external training, or other reasons; (2)Non-permanent medical staff such as trainees, interns, or rotating personnel.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Injection site pain intensity;Incidence and severity of local induration;Incidence of drug leakage; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adherence to Self-Management;Level of Knowledge on Fulvestrant Injection Management Among Nurses and Patients;Nurses' Adherence to Fulvestrant Injection Administration Protocols;Nurses' and Patients' Experiences of the Intervention; | — |
Countries
China
Contacts
Fudan University Shanghai Cancer Center